Template:Anaplastic large cell lymphoma: Difference between revisions

	Anaplastic large cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anaplastic large cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anaplastic large cell lymphoma On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anaplastic large cell lymphoma All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anaplastic large cell lymphoma
CDC on Anaplastic large cell lymphoma
Anaplastic large cell lymphoma in the news
Blogs on Anaplastic large cell lymphoma
Directions to Hospitals Treating Anaplastic large cell lymphoma
Risk calculators and risk factors for Anaplastic large cell lymphoma

@@ Line 11: / Line 11: @@
 !
 [[Anaplastic large cell lymphoma|Home]]
+|-
+!
+|- bgcolor="Pink"
+!
+[[Anaplastic large cell lymphoma patient information|Patient Information]]
 |-
 !
@@ Line 77: / Line 83: @@
 !
 Diagnosis
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Anaplastic large cell lymphoma diagnostic study of choice|Diagnostic Study of Choice]]
 |-
 !
@@ Line 95: / Line 107: @@
 !
 [[Anaplastic large cell lymphoma laboratory findings|Laboratory Findings]]
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Anaplastic large cell lymphoma chest x ray|Chest X Ray]]
 |-
 !
@@ Line 150: / Line 168: @@
 [[Anaplastic large cell lymphoma primary prevention|Primary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"
@@ Line 156: / Line 174: @@
 [[Anaplastic large cell lymphoma secondary prevention|Secondary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"

Latest revision as of 18:11, 17 December 2018